Green Cross Lab Cell Corporation - Asset Resilience Ratio

Latest as of September 2025: 0.18%

Green Cross Lab Cell Corporation (144510) has an Asset Resilience Ratio of 0.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 144510 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩1.00 Billion

≈ $677.69K USD Cash + Short-term Investments

Total Assets

₩565.79 Billion

≈ $383.43 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Green Cross Lab Cell Corporation's Asset Resilience Ratio has changed over time. See 144510 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Green Cross Lab Cell Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Green Cross Lab Cell Corporation market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.00 Billion	0.18%
Total Liquid Assets	₩1.00 Billion	0.18%

Asset Resilience Insights

Limited Liquidity: Green Cross Lab Cell Corporation maintains only 0.18% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Green Cross Lab Cell Corporation Industry Peers by Asset Resilience Ratio

Compare Green Cross Lab Cell Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	6.56%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Green Cross Lab Cell Corporation (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Green Cross Lab Cell Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.00%	₩-9.81K ≈ $-6.65	₩578.35 Billion ≈ $391.94 Million	+0.00pp
2023-12-31	0.00%	₩-39.99K ≈ $-27.10	₩665.17 Billion ≈ $450.78 Million	-7.00pp
2022-12-31	7.00%	₩47.37 Billion ≈ $32.10 Million	₩676.53 Billion ≈ $458.48 Million	+3.90pp
2021-12-31	3.10%	₩20.01 Billion ≈ $13.56 Million	₩645.57 Billion ≈ $437.50 Million	-12.76pp
2020-12-31	15.86%	₩12.11 Billion ≈ $8.21 Million	₩76.36 Billion ≈ $51.75 Million	-4.10pp
2019-12-31	19.97%	₩13.59 Billion ≈ $9.21 Million	₩68.06 Billion ≈ $46.13 Million	-29.42pp
2018-12-31	49.39%	₩28.28 Billion ≈ $19.17 Million	₩57.27 Billion ≈ $38.81 Million	-20.32pp
2017-12-31	69.70%	₩38.58 Billion ≈ $26.15 Million	₩55.36 Billion ≈ $37.51 Million	-2.60pp
2016-12-31	72.30%	₩39.41 Billion ≈ $26.71 Million	₩54.51 Billion ≈ $36.94 Million	+49.76pp
2015-12-31	22.53%	₩3.80 Billion ≈ $2.58 Million	₩16.86 Billion ≈ $11.43 Million	--

pp = percentage points

About Green Cross Lab Cell Corporation

KQ:144510 Korea Diagnostics & Research

Market Cap

$241.86 Million

₩356.89 Billion KRW

Market Cap Rank

#15826 Global

#627 in Korea

Share Price

₩23750.00

Change (1 day)

-2.66%

52-Week Range

₩18280.00 - ₩27500.00

All Time High

₩126167.70